Leonard John M, President and CEO of Intellia Therapeutics ($NTLA), sold shares on the open market four times in the last year, totaling $1.15 million. His most recent sale occurred on January 5, 2026. These sales rank 4,596th among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | A | Stock Option (right to buy) | 225400 | $0.00 | 225,400.0000 | 115,829,926 | 9999.99% | 0.19% |
| March 1, 2026 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | A | Common Stock | 156400 | $0.00 | 1,228,154.0000 | 115,829,926 | 14.59% | 0.14% |
| Jan. 5, 2026 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | S | Common Stock | 34146 | $9.21 | 1,071,754.0000 | 115,829,926 | 3.09% | 0.03% |
| Dec. 12, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | M | Common Stock | 8557 | $6.83 | 1,105,900.0000 | 115,829,926 | 0.78% | 0.01% |
| Dec. 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | S | Common Stock | 5355 | $9.59 | 1,097,343.0000 | 115,829,926 | 0.49% | 0.00% |
| Dec. 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | S | Common Stock | 32832 | $9.47 | 1,102,698.0000 | 115,829,926 | 2.89% | 0.03% |
| Dec. 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | M | Common Stock | 49959 | $6.83 | 1,185,489.0000 | 115,829,926 | 4.40% | 0.04% |
| Dec. 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | S | Common Stock | 49959 | $9.49 | 1,135,530.0000 | 115,829,926 | 4.21% | 0.04% |
| Dec. 12, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | M | Stock Option (right to buy) | 8557 | $0.00 | 0.0000 | 115,829,926 | 100.00% | 0.01% |
| Dec. 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | M | Stock Option (right to buy) | 49959 | $0.00 | 8,557.0000 | 115,829,926 | 85.38% | 0.04% |
| April 24, 2025 | IQVIA HOLDINGS INC. | $IQV | LEONARD JOHN M | Director | A | Common Stock | 1592 | $0.00 | 15,375.0000 | 258,500,000 | 11.55% | 0.00% |
| March 1, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | A | Common Stock | 136000 | $0.00 | 1,135,530.0000 | 103,517,460 | 13.61% | 0.13% |
| March 1, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | A | Stock Option (right to buy) | 196000 | $0.00 | 196,000.0000 | 103,517,460 | 9999.99% | 0.19% |
| Jan. 3, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | S | Common Stock | 26807 | $12.18 | 999,530.0000 | 0 | 2.61% | 0.00% |
| Jan. 1, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | M | Restricted Stock Unit | 7850 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 1, 2025 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | M | Common Stock | 7850 | $0.00 | 1,026,337.0000 | 0 | 0.77% | 0.00% |
| May 7, 2024 | IQVIA HOLDINGS INC. | $IQV | LEONARD JOHN M | Director | A | Common Stock | 1047 | $0.00 | 13,783.0000 | 257,899,999 | 8.22% | 0.00% |
| March 1, 2024 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | A | Stock Option (right to buy) | 163929 | $0.00 | 163,929.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | A | Common Stock | 113586 | $0.00 | 1,018,487.0000 | 0 | 12.55% | 0.00% |
| Jan. 3, 2024 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | S | Common Stock | 19223 | $29.46 | 904,901.0000 | 0 | 2.08% | 0.00% |
| Jan. 1, 2024 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | M | Common Stock | 7848 | $0.00 | 924,124.0000 | 0 | 0.86% | 0.00% |
| Jan. 1, 2024 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | M | Restricted Stock Unit | 7848 | $0.00 | 7,850.0000 | 0 | 49.99% | 0.00% |
| March 1, 2023 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | A | Stock Option (right to buy) | 128631 | $0.00 | 128,631.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | A | Common Stock | 91036 | $0.00 | 916,276.0000 | 0 | 11.03% | 0.00% |
| Jan. 4, 2023 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | S | Common Stock | 6673 | $37.21 | 825,240.0000 | 0 | 0.80% | 0.00% |
| Jan. 1, 2023 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | M | Restricted Stock Unit | 7848 | $0.00 | 15,698.0000 | 0 | 33.33% | 0.00% |
| Jan. 1, 2023 | Intellia Therapeutics, Inc. | $NTLA | LEONARD JOHN M | President and CEO | M | Common Stock | 7848 | $0.00 | 831,913.0000 | 0 | 0.95% | 0.00% |